Evaluation of the Polygenic Risk Score for Alzheimer’s Disease in Russian Patients with Dementia Using a Low-Density Hydrogel Oligonucleotide Microarray
Authors:
- Anna IkonnikovaAIAnna Ikonnikova
- Anna MorozovaAMAnna Morozova
- Olga AntonovaOAOlga Antonova
- Alexandra OchnevaAOAlexandra Ochneva
- Elena FedoseevaEFElena Fedoseeva
- Olga AbramovaOAOlga Abramova
- Marina EmelyanovaMEMarina Emelyanova
- Marina FilippovaMFMarina Filippova
- Irina MorozovaIMIrina Morozova
- Yana ZorkinaYZYana Zorkina
- Timur SyunyakovTSTimur Syunyakov
- Alisa AndryushchenkoAAAlisa Andryushchenko
Open Access
- 29 September 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (19) , 14765
Abstract
The polygenic risk score (PRS), together with the ɛ4 allele of the APOE gene (APOE-ɛ4), has shown high potential for Alzheimer’s disease (AD) risk prediction. The aim of this study was to validate the model of polygenic risk in Russian patients with dementia. A microarray-based assay was developed to identify 21 markers of polygenic risk and ɛ alleles of the APOE gene. This case–control study included 348 dementia patients and 519 cognitively normal volunteers. Cerebrospinal fluid (CSF) amyloid-β (Aβ) and tau protein levels were assessed in 57 dementia patients. PRS and APOE-ɛ4 were significant genetic risk factors for dementia. Adjusted for APOE-ɛ4, individuals with PRS corresponding to the fourth quartile had an increased risk of dementia compared to the first quartile (OR 1.85; p-value 0.002). The area under the curve (AUC) was 0.559 for the PRS model only, and the inclusion of APOE-ɛ4 improved the AUC to 0.604. PRS was positively correlated with tTau and pTau181 and inversely correlated with Aβ42/Aβ40 ratio. Carriers of APOE-ɛ4 had higher levels of tTau and pTau181 and lower levels of Aβ42 and Aβ42/Aβ40. The developed assay can be part of a strategy for assessing individuals for AD risk, with the purpose of assisting primary preventive interventions.Keywords
Funding Information
- Moscow Centre for Innovative Technologies in Healthcare (0803-4/23)
This publication has 44 references indexed in Scilit:
- Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-upAlzheimer Disease & Associated Disorders, 2016
- An Alzheimer’s Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adultseneuro, 2016
- Assessment of the genetic variance of late-onset Alzheimer's diseaseNeurobiology of Aging, 2016
- Common polygenic variation enhances risk prediction for Alzheimer’s diseaseBrain, 2015
- A 22‐single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42Alzheimer's & Dementia, 2015
- A non-invasive, rapid method to genotype late-onset Alzheimer′s disease-related apolipoprotein E gene polymorphismsNeural Regeneration Research, 2014
- SNPStats: a web tool for the analysis of association studiesBioinformatics, 2006
- Focus on Alzheimer's Disease and Related DisordersThe Journal of Clinical Psychiatry, 2005
- A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease.2005
- Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer DiseaseJAMA, 2003